Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 464


Anastrozole-Induced Carpal Tunnel Syndrome: Results From the International Breast Cancer Intervention Study II Prevention Trial.

Spagnolo F, Sestak I, Howell A, Forbes JF, Cuzick J.

J Clin Oncol. 2015 Nov 23. pii: JCO634972. [Epub ahead of print]


Cancer Prevention: Obstacles, Challenges and the Road Ahead.

Meyskens FL Jr, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, Ramsey SD, Lippman SM, Alberts DS.

J Natl Cancer Inst. 2015 Nov 7;108(2). pii: djv309. doi: 10.1093/jnci/djv309. Print 2016 Feb.


Risk Stratification using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-wide Surveillance Program.

Gage JC, Hunt WC, Schiffman M, Katki HA, Cheung LC, Cuzick J, Myers O, Castle PE, Wheeler CM, Group Author NM.

Cancer Epidemiol Biomarkers Prev. 2015 Oct 30. pii: cebp.0669.2015. [Epub ahead of print]


Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer.

Cuzick J.

Ann Oncol. 2015 Dec;26(12):2363-6. doi: 10.1093/annonc/mdv392. Epub 2015 Oct 3. Review.


Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.

Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM; New Mexico HPV Pap Registry Steering Committee.

Ann Intern Med. 2015 Oct 20;163(8):589-97. doi: 10.7326/M15-0420. Epub 2015 Sep 29.


HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier.

Brentnall AR, Vasiljevic N, Scibior-Bentkowska D, Cadman L, Austin J, Cuzick J, Lorincz AT.

Cancer Biomark. 2015 Sep 21;15(5):669-75. doi: 10.3233/CBM-150507.


HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

Bosch FX, Robles C, Díaz M, Arbyn M, Baussano I, Clavel C, Ronco G, Dillner J, Lehtinen M, Petry KU, Poljak M, Kjaer SK, Meijer CJ, Garland SM, Salmerón J, Castellsagué X, Bruni L, de Sanjosé S, Cuzick J.

Nat Rev Clin Oncol. 2015 Sep 1. doi: 10.1038/nrclinonc.2015.146. [Epub ahead of print] Review.


Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study.

Reid JL, Wright TC Jr, Stoler MH, Cuzick J, Castle PE, Dockter J, Getman D, Giachetti C.

Am J Clin Pathol. 2015 Sep;144(3):473-83. doi: 10.1309/AJCPHVD7MIP3FYVV.


Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial.

DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, Lazzeroni M, Vingiani A, Gentilini O, Petrera M, Viale G, Cuzick J, Bonanni B, Pruneri G.

Cancer Prev Res (Phila). 2015 Oct;8(10):888-94. doi: 10.1158/1940-6207.CAPR-15-0048. Epub 2015 Aug 14.


Impact of preventive therapy on the risk of breast cancer among women with benign breast disease.

Cuzick J, Sestak I, Thorat MA.

Breast. 2015 Nov;24 Suppl 2:S51-5. doi: 10.1016/j.breast.2015.07.013.


Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes RC, Cuzick J, Dubsky P, Gnant M, Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann B, van de Velde C, Pan H, Peto R, Davies C, Gray R.

Lancet. 2015 Oct 3;386(10001):1341-52. doi: 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23.


In Regard to Vaidya et al.

Haviland JS, Bliss JM, Bentzen SM, Cuzick J.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):954-5. doi: 10.1016/j.ijrobp.2015.05.026. Epub 2015 Jul 14. No abstract available.


Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort.

Cuzick J, Stone S, Fisher G, Yang ZH, North BV, Berney DM, Beltran L, Greenberg D, Møller H, Reid JE, Gutin A, Lanchbury JS, Brawer M, Scardino P.

Br J Cancer. 2015 Jul 28;113(3):382-9. doi: 10.1038/bjc.2015.223. Epub 2015 Jun 23.


Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer.

Dowsett M, Sestak I, Buus R, Lopez-Knowles E, Mallon E, Howell A, Forbes JF, Buzdar A, Cuzick J.

Clin Cancer Res. 2015 Jun 15;21(12):2763-70. doi: 10.1158/1078-0432.CCR-14-2842.


Background risk of breast cancer influences the association between alcohol consumption and mammographic density.

Trinh T, Christensen SE, Brand JS, Cuzick J, Czene K, Sjölander A, Bälter K, Hall P.

Br J Cancer. 2015 Jun 30;113(1):159-65. doi: 10.1038/bjc.2015.185. Epub 2015 Jun 2.


Gardasil 9 joins the fight against cervix cancer.

Cuzick J.

Expert Rev Vaccines. 2015;14(8):1047-9. doi: 10.1586/14760584.2015.1051470. Epub 2015 May 31.


Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.

Gnant M, Sestak I, Filipits M, Dowsett M, Balic M, Lopez-Knowles E, Greil R, Dubsky P, Stoeger H, Rudas M, Jakesz R, Ferree S, Cowens JW, Nielsen T, Schaper C, Fesl C, Cuzick J.

Ann Oncol. 2015 Aug;26(8):1685-91. doi: 10.1093/annonc/mdv215. Epub 2015 May 1.


Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.

Mote PA, Gompel A, Howe C, Hilton HN, Sestak I, Cuzick J, Dowsett M, Hugol D, Forgez P, Byth K, Graham JD, Clarke CL.

Breast Cancer Res Treat. 2015 Jun;151(2):309-18. doi: 10.1007/s10549-015-3397-0. Epub 2015 Apr 28.


Background risk of breast cancer and the association between physical activity and mammographic density.

Trinh T, Eriksson M, Darabi H, Bonn SE, Brand JS, Cuzick J, Czene K, Sjölander A, Bälter K, Hall P.

Breast Cancer Res. 2015 Apr 2;17:50. doi: 10.1186/s13058-015-0565-4.


Markers for the identification of late breast cancer recurrence.

Sestak I, Cuzick J.

Breast Cancer Res. 2015 Jan 27;17:10. doi: 10.1186/s13058-015-0516-0.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk